ESR1 and ductal breast carcinoma in situ: Studies on the use of letrozole in preoperative hormonal therapy in premenopausal patients with ER-positive DCIS have shown that it may result in a significant reduction in tumor volume and change in biological markers and may signal non-surgical management in a selected patient population [229].